Company Information

CIN
Status
Date of Incorporation
02 April 1993
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 December 2022
Paid Up Capital
1,564,807,680
Authorised Capital
30,000,000,000

Directors

Rajendrakumar Padmanabhan Kaimal
Rajendrakumar Padmanabhan Kaimal
Director/Designated Partner
almost 2 years ago
Ashish Mohan Ujagare
Ashish Mohan Ujagare
Director/Designated Partner
almost 7 years ago
Ajit Annu Kamath
Ajit Annu Kamath
Director/Designated Partner
about 7 years ago
Vikas Bijay Kedia
Vikas Bijay Kedia
Director/Designated Partner
about 8 years ago
Ramakant Madhav Nayak
Ramakant Madhav Nayak
Director
about 14 years ago
Jayanta Kumar Banerjee
Jayanta Kumar Banerjee
Nominee Director
almost 16 years ago
Srinivas Koppisetty
Srinivas Koppisetty
Nominee Director
almost 18 years ago
Vandana Rajadhyaksha
Vandana Rajadhyaksha
Nominee Director
over 18 years ago
Aluri Rao Srinivasa
Aluri Rao Srinivasa
Nominee Director
over 20 years ago
Mallikarjuna Reddy Tirumalareddy
Mallikarjuna Reddy Tirumalareddy
Wholetime Director
over 32 years ago

Past Directors

Palak Bipin Shah
Palak Bipin Shah
Additional Director
over 8 years ago
Sunil Mansukhlal Pitroda
Sunil Mansukhlal Pitroda
Additional Director
over 8 years ago
Abhishek Deepak Buddhadev
Abhishek Deepak Buddhadev
Additional Director
over 8 years ago
Shantilal Dalichand Jain
Shantilal Dalichand Jain
Director
about 14 years ago
Hira Sadhak
Hira Sadhak
Additional Director
almost 15 years ago
Puthenveetil Vincent John
Puthenveetil Vincent John
Additional Director
almost 15 years ago
Rajiv Sarman Shukla
Rajiv Sarman Shukla
Nominee Director
over 17 years ago
Sunil Vasant Diwakar
Sunil Vasant Diwakar
Nominee Director
almost 18 years ago
Pramod Devadas Shedde
Pramod Devadas Shedde
Nominee Director
over 19 years ago
Manoj Tejraj Jain
Manoj Tejraj Jain
Whole Time Director
about 22 years ago

Patents

"A Short Process For The Preparation Of Ziprasidone And Intermediates Thereof".

A process for the preparation of oxindole derivative (Ziprasidone hydrochloride) of formula (I) comprising reacting compound of formula (II) with Sn and HC1 to give compound of formula (III) in a single step which is converted into compound of formula IV which is a key intermediate for the preparation of compound of...

An Improved Process For The Preparation Of Racemic 6, 6 Dimethyl 3 Azabicyclo [3.1.0.] Hexane And Its Salts, A Key Raw Material For Hcv Inhibitor.

The present invention discloses an improved process for the preparation of racemic 6, 6-dimethyl-3-azabicyclo-[3.1.0]-hexane of formula I and its salts. The invention relates to the compounds of formulae I and II. The compound of formula I is a key raw material for the preparation of key intermediate (1R, 2S, 5S) - ...

An Improved Process For Preparing 2 Oxindoles Of Formula I, A Key Raw Material For Making Pharmaceutical Drugs And Intermediates Thereof.

The present invention provides an improved processes having practical utility for preparing 2-oxindoles of formula I comprising preparation of 2-nitroarylmalonate diester of formula II as first intermediate and subsequent insitu reductive cyclisation using metal acid combination and its modified work-up to form comp...

An Improved Process For The Preparation Of Pharmaceutically Acceptable Salts Of Racemic Milnacipran And Its Optical Enantiomers Thereof.

The present invention relates to an improved process for the preparation of pharmaceutically acceptable salts of milnacipran by mutual acid radical exchange.

A Continuous Green Process For The Preparation Of Alkyl (Aminophenyl) Carbamate Of Formula I.

The subject invention relates to a continuous green process for the preparation of alkyl-(aminophenyl)-carbamate of formula-I comprising contacting substrate diaminobenzene (also known as phenylenediamine) of formula-II with substrate alkyl haloformate of formula-III in water as a green reaction medium without using...

An Improved Process For The Preparation Of 4 Substituted 1, 4 Dihydropyridines Of Formula Analogs Thereof

: 4-Substituted-1,4-dihydropyridines of formula I are prepared by a cycloaddition reaction in which the cyclization is driven to completion at ambient temperature optionally in water without any catalyst. For exemplary purposes, the invention is described in particular detail with respect to the preparation of felod...

An Improved Process For The Preparation Of Substantially Pure N Carbamoyl Tert Leucine Of The Formulae I/Ia.

The present invention provides an efficient process for the preparation of substantially pure N-carbamoyl-tert leucine of formula I which is a key intermediate for the preparation of various therapeutic agents or a therapeutic agent precursor used as ("HCV") protease inhibitors. The present invention relates to a pr...

"Process For The Preparation Of Donepezil Intermediate"

Disclosed herein is an efficient process for the preparation of N-benzyl 4- formyl piperidine of formula-l which is a key intermediate for the preparation of acetylcholinesterase inhibitor donepezil hydrochloride (I), chemically known as (+-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)- 4-piperidinyl]methyl]-...

"A Novel Process For The Preparaton Of Iloperidone And Pharmaceutically Acceptable Salts Thereof".

The present invention relates to a new process for the preparation of 1-[4-[3-[4-(6-fluoro- l,2-benzisoxazol-3-yl)- l-piperidinyl]propoxy]-3-methoxyphenyl]- ethanone (Iloperidone) and salts thereof The synthetic process comprises the reaction between itself 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole of formula II ...

An Improved Process For Preparation Of Dronedarone Intermediate,Dronedarone And Pharmaceutically Acceptable Salts Thereof

Present invention is to provide in-situ preparation of intermediates, Dronedarone and pharmaceutically acceptable salts thereof in higher yield and purity starting from 2-n-butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran. The said process is carried out without isolation and purification of intermediates and is particu...

An Improved, Industrially Safe And Economical Process For The Preparation Of Benzoxazole Of Formula I; A Key Intermediate For The Preparation Of Mk 4305

Disclosed herein is an improved process for the preparation of Benzoxazole of formula I; a key intermediate for the preparation of MK-4305 via an advanced intermediate of formula II depicted herein above. The process comprises chip and commercially available starting materials using novel chemistry to synthesize ben...

An Improved Proces For The Preparation Of Key Intermediate Of Atorvastatin

The present invention relates to an advanced and improved process over the prior art for the preparation of 4-fluoro-a-[2-methyl-l-oxopropyl]-y-oxo-N-P-diphenylbenzenebutanamide of the formula I commercially referred as DKT III, a key intermediate for the synthesis of Atorvastatin and pharmaceutically acceptable sal...

"Process For The Preparation Of Substituted Amine Hydrochloride And Hydrates Thereof Key Raw Material For A Large No Of Pharmaceutical Drugs".

This invention is directed to an efficient and economical process for the preparation of substituted amine hydro halides of formula I, particularly to N.N-dimethylamine hydrochloride of formula II and hydrates thereof; and its further use for making various APIs.

A Process For The Preparation Of 2 Oxindoles Of Formula I

Disclosed herein is an improved, economical and ecofriendly single step hydrogenation process using raney nickel for the preparation of 2-oxindoles of formula I preferably IA with less sulphated ash, high HPLC assay and high HPLC purity.

Process For The Preparation Of Stable Lamivudine Form I

Disclosed herein is an efficient and industrially viable process for the preparation of stable crystalline Form-I of Lamivudine comprising heating lamivudine in solid powdered, amorphous or any other crystalline form in an alcoholic solvent preferably methanol upto its reflux temperature to obtain a suspension and t...

Novel Polymorph Of Retigabine Dihydrochloride Of Formula I And Process For Preparation.

Disclosed herein are two different crystalline polymorphic forms of retigabine dihydrochloride of formula I referred as form I and form II. These forms are characterized by their 20 values on XRD and their crystal shapes. It also describes the process for the preparation of these forms.

"A Novel Process For The Preparation Of 3 Benzyloxybenzenthiol, A Key Intermediate For The Preparation Of Pharmaceutical Drugs."

Disclosed herein is an efficient and economical process for the preparation of 3-Benzyloxybenzenethiol of formula-I which is a key intermediate for the preparation of pharmaceutical drugs. R" is hydrogen, halogen, trihalomethyl, lower alkoxy having 1-4 carbon atoms, lower alkyl having 1-7 carbon atoms, substituted ...

Novel Process For Preparation Of Duloxetine And Intermediates For Use Therein

The present invention relates to salts of (S)-(+)-N-methyl-3-(l-naphthalenyloxy)-3-(2-thiophenyl) propanamine more particularly Lewis acid salts of duloxetine of the formula I and further it relates to a process of preparation of salts of (S)-(+)-N-methyl-3-(l-naphthalenyloxy)-3-(2-thiophenyl) propanamine, more par...

An Improved Process For The Preparation Of Flupirtine And Pharmaceutically Acceptable Salts Thereof

The invention relates to an improved process for the preparation of flupirtine (I) and its pharmaceutically acceptable salts, especially of flupirtine maleate (IA), and pure crystal modification. A of flupirtine maleate.

A Novel Process For The Preparation Of Strontium Ranelate And Its Pharmaceutically Acceptable Salts Thereof.

Disclosed herein is an improved, commercially viable and industrially advantageous novel process for the preparation of Strontium ranelate of formula I chemically known as distrontium 5-[bis(2-oxido-2-oxoethyl)amino]-4-cyano-3-(2-oxido-2-oxoethyl)thiophene-2-carboxylate or 5-[bis(carboxymethyl)amino]-2-carboxy-4-cya...

Preparation Of Novel Crystalline Form Of Quinapril Hydrochloride

N/A

An Improved Process For The Preparation Of 4 Fluoro A [2 Methyl Loxopropyl] ? Oxo N ß Diphenylbenzenebutanamide,

A novel process for the preparation of 4-fluoro-α-[2-methyl-l-oxopropyl]-Y-oxo-N-p-diphenylbenzenebutanamide also known as 2-[2-(4-fluorophenyl)-2-oxo-l-phenylethyl]-4-niethyl-3-oxo-pentanoic acid phenylamiclc of the formula I containing about 0.1% or less of α-[2-methyl-l-oxopropyl]-y-oxo-N-β-diphenylbenzene butana...

A Green Chemistry Process For The Preparation Of Pregnadiene Ester

A process for the preparation of Pregna-1, 4-diene – 3,20-dione-16,17-acetal-21 esters of Formula (I) by green process chemistry unsing a combination of an ionic liquid, organic solvent optionally in the presence of an inorganic nitrite. Wherein R amd R’ represent a) R=H,R-cyclohexyl or b)R=CO-CH(CH3)2,R’=cyclohexyl...

An Improved Process For Preparing High Purity Ethyl (R) 4 Cyano 3 Hydroxy Butyric Acid Ester/Butyrate

A process for the preparation of alkyI-(R)-4-cyano-3-hydroxybutyrate of Formula I in high optical purity of about 99.9%, having S enatiomer less than about 0.1% and low moisture content of about 0.16-0.19%, while minimizing the level of hydrogen cyanide production, which comprises the steps of: i. Providing alk...

An Efficient Process For The Preparation Of Beta Lactams Used As An Intermediate In The Synthesis Of Carbapenem Antibiotics

The present invention provides a process for producing a compound of formula I which is an important pharmaceutical intermediate, particularly an intermediate of an carbapeneum antibiotics. Formula I Ri is selected from the group of H, C1-C4 alkyl group, Secondary alcoholic group, and Secondary thioalcoholic group...

"An Improved Process For The Preparation Of Imatinib And Salts Thereof"

Disclosed herein is a process for preparation of imatinib free base which comprises condensing 4-Methyl-N-(4-pyridin-3-yl-pyrimidin-2-yl)-benzene-l,3-diamine with 4-(4-Methyl-piperazin-l-ylmethyl)-benzoic acid ester in the presence of base including organic bases and inorganic bases in an organic solvent to form ima...

An Improved Process For The Preparation Of 5 Hydroxy 3 Oxopentanoic Acid Derivatives

The present invention provides a process for producing a 5-hydroxy-3-oxo pentatonic acid derivative of formula I which is an important pharmaceutical intermediate, particularly an intermediate of an HMG-COA reductase inhibitor.

Process For The Preparation Of Clopidogrel Base Or Its Alcoholic Solution/ Suspension With Improved Stability

A novel process for the preparation of stable clopidogrel base of formula I or its alcoholic solution/suspension having improved stability during storage over extended periods of time suitable for pharmaceutical use and as an intermediate for making pharmaceutically accepted salts and for its use for the preparation...

A Novel Process For The Preparation Of Gemcitabine Hydrochloride Of Formula 1

Disclosed herein is an novel process for the preparation of Gemcitabine Hydrochloride (2"-deoxy-2",2"-difluorocytidine hydrochloride) of the formula I comprising asymmetrical chemical reaction between difluoroacetic acid coupled with chiral auxiliary and protected glycerafdehydes to obtain a sterospecific isomer of ...

Novel Process For The Preparation, Isolation And Purification Of Gemcitabine Hydrochloride And Intermediates Thereof

An improved one pot process for preparing 2-deoxy-D-erythro-2,2-difluoro-pentafuranose-1-ulose-3,5-dibenzoate of Formula (I) comprising hydrolysis of (erythro:threo) alkyl-3-dioxalan-4-yl-2,2-difluoro-3-hydroxy propionate of Formula (III) where alkyl group is having C1-C4 number of Carbon atoms using a mild acid and...

A Novel Process For The Preparation Of N Methyl O Aryloxy Propanamine Derivatives And Pharmaceutically Acceptable Salt Thereof

A process for the preparation on N-methyl- aryloxy-propanamine derivatives of the formula I and salts thereof. The invention also relates to the preparation and use novel intermediate of the formula XII. The invention also relates to the process of further conversion of novel intermediate into N-methyl- aryloxy prop...

Process For Preparing Anhydrous Rare Earth Metal Halides

A process for the preparation of anhydrous rare earth metal halides comprising forming slurry of said rare earth metal hydrates in aromatic hydrocarbon and removal of water by azeotropic distillation.

"Purification Of Montelukast Using A Simulated Moving Bed".

This invention concerns generally with a process for purifying crude pharmaceutical compositions, wherein the crude pharmaceutical composition comprises a sodium salt of Montelukast and more particularly relates to a process for the production of pharmaceutically pure preparations of Montelukast sodium using sim...

Process For The Preparation Of Retigabine Of The Formula I And Pharmaceutically Acceptable Salts Thereof

The invention relates to process for the preparation of 2-amino-4-(4-fluorobenzylamino)-l-ethoxycarbonylaminobenzene generically known as Retigabine of the formula (I) and its pharmaceutically acceptable salts e.g. Formula IA, particularly to the modification over the prior art processes-I and II disclosed therein i...

An Improved Process For The Preparation Of Substantially Pure Strontium Ranelate Of Formula I And Hydrates Thereof Of Formula Ia.

The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of substantially pure strontium ranelate of formula I and hydrates thereof.

A New Process For Preparing Optically Pure Milnacipran And Its Pharmaceutically Acceptable Salts

The present invention relates to an improved and commercially viable process for the resolution of racemic cis milnacipran of formula I and its pharmaceutically acceptable salts of formula II. The present invention comprises using racemic cis milnacipran or its pharmaceutically acceptable salts as starting material,...

An Improved Process For The Preparation Of Beta Keto Esters Of Formula I.

The instant invention relates to an improved batch process for the preparation of formula I by cross Claisen condensation using lithium metal amine chemically represented as LiNH2 of formula II as lithium source over conventionally used n-butyl lithium, lithium diisopropylamide referred as LDA, lithium hexamethyldis...

"An Improved And Commercially Viable Process For Preparation Of Pyrrole Derivatives With Imporved ..

ABSTRACT: The present invention relates to improved process for the preparation of a pyrrole derivative as a racemic mixture, an enantiomer, a diastereoisomer, a mixture thereof, a tautomer thereof or a pharmaceutically acceptable salt and hydrates thereof and also intermediates involved therein. Particularly inven...

Registered Trademarks

Araca (Device) Arch Pharmalabs

[Class : 5] Chemico Pharmaceutical Preparations.

Charges

5,636 Crore
04 December 2017
Jm Financial Asset Reconstruction Company Limited
200 Crore
27 September 2013
Jm Financial Asset Reconstruction Company Private Limited
582 Crore
16 July 2013
Jm Financial Asset Reconstruction Company Private Limited
11 Crore
24 April 2013
Vistra Itcl (india) Limited
75 Crore
21 March 2013
Jm Financial Asset Reconstruction Company Private Limited
100 Crore
05 February 2013
Jm Financial Asset Reconstruction Company Limited
25 Crore
14 January 2013
Jm Financial Asset Reconstruction Company Private Limited
12 Crore
27 September 2012
Jm Financial Asset Reconstruction Company Limited
100 Crore
27 July 2012
Jm Financial Asset Reconstruction Company Limited
15 Crore
12 July 2012
Axis Trustee Services Limited
20 Crore
20 June 2012
Jm Financial Asset Reconstruction Company Limited
25 Crore
02 May 2012
Canara Bank
10 Crore
28 March 2012
Jm Financial Asset Reconstruction Company Limited
30 Crore
30 January 2012
Jm Financial Asset Reconstruction Company Limited
100 Crore
20 December 2011
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
14 December 2011
Jm Financial Asset Reconstruction Company Limited
100 Crore
21 October 2011
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
24 September 2011
Jm Financial Asset Reconstruction Company Private Limited
49 Crore
19 August 2011
Jm Financial Asset Reconstruction Company Limited
20 Crore
17 August 2011
Axis Trustee Services Limited
100 Crore
25 April 2011
Jm Financial Asset Reconstruction Company Private Limited
100 Crore
07 April 2011
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
31 March 2011
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
28 February 2011
Jm Financial Asset Reconstruction Company Private Limited
100 Crore
27 December 2010
Jm Financial Asset Reconstruction Company Private Limited
250 Crore
28 September 2010
Jm Financial Asset Reconstruction Company Limited
70 Crore
17 March 2010
Jm Financial Asset Reconstruction Company Limited
7 Crore
12 March 2010
Jm Financial Asset Reconstruction Company Limited
32 Crore
09 March 2010
Jm Financial Asset Reconstruction Company Limited
35 Crore
20 January 2010
Jm Financial Asset Reconstruction Company Private Limited
20 Crore
10 October 2009
Jm Financial Asset Reconstruction Company Limited
48 Crore
22 September 2009
Jm Financial Asset Reconstruction Company Private Limited
40 Crore
04 September 2009
Jm Financial Asset Reconstruction Company Private Limited
25 Crore
20 July 2009
Jm Financial Asset Reconstruction Company Private Limited
55 Crore
25 February 2009
Jm Financial Asset Reconstruction Company Limited
60 Crore
11 February 2009
Vistra Itcl (india) Limited
75 Crore
22 January 2009
Standard Chartered Bank
10 Crore
02 January 2009
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
08 April 2008
Jm Financial Asset Reconstruction Company Private Limited
150 Crore
30 August 2007
Canara Bank
40 Crore
04 July 2007
Centurion Bank Of Punjab
10 Crore
05 January 2007
Axis Trustee Services Limited
2,035 Crore
21 July 2006
State Bank Of Indore
34 Crore
04 May 2005
Jm Financial Asset Reconstruction Company Private Limited
62 Crore
10 March 2005
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
10 March 2005
Jm Financial Asset Reconstruction Company Private Limited
50 Crore
31 December 2004
Jm Financial Asset Reconstruction Company Private Limited
86 Crore
20 December 1999
Jm Financial Asset Reconstruction Company Private Limited
163 Crore
30 October 2009
Indian Overseas Bank
10 Crore
21 July 2009
Development Credit Bank Limited
15 Crore
30 August 2006
Yes Bank Limited
25 Crore
25 March 2009
Bank Of India
25 Crore
03 July 2007
Idbi Trusteeship Services Limited
40 Crore
28 April 2010
State Bank Of Indore
20 Crore
04 October 2010
Punjab National Bank
50 Crore
12 December 2005
State Bank Of Patiala
6 Crore
03 December 2009
State Bank Of Patiala
15 Crore
23 October 2006
D B S Bank Limited
10 Crore
17 January 2009
Punjab National Bank
50 Crore
08 July 2009
Bank Of Bahrain & Kuwait Bsc
15 Crore
22 June 2004
Hdfc Bank Limited
20 Crore
23 September 2006
Centurion Bank Of Punjab Limited
10 Crore
20 July 2021
Rbl Bank Limited
5 Lak
27 May 2021
Jm Financial Asset Reconstruction Company Limited
200 Crore
29 March 2022
Others
0
04 December 2017
Others
0
05 January 2007
Others
0
20 July 2021
Others
0
27 May 2021
Others
0
02 January 2009
Others
0
11 February 2009
Others
0
25 February 2009
Others
0
20 July 2009
Others
0
04 September 2009
Others
0
22 September 2009
Others
0
20 January 2010
Others
0
09 March 2010
Others
0
12 March 2010
Others
0
17 March 2010
Others
0
28 September 2010
Others
0
27 December 2010
Others
0
31 March 2011
Others
0
07 April 2011
Others
0
25 April 2011
Others
0
24 September 2011
Others
0
19 August 2011
Others
0
28 February 2011
Others
0
21 October 2011
Others
0
20 December 2011
Others
0
28 March 2012
Others
0
27 September 2012
Others
0
14 January 2013
Others
0
05 February 2013
Others
0
21 March 2013
Others
0
24 April 2013
Others
0
20 June 2012
Others
0
16 July 2013
Others
0
27 September 2013
Others
0
20 December 1999
Others
0
31 December 2004
Others
0
04 May 2005
Others
0
10 March 2005
Others
0
10 March 2005
Others
0
22 June 2004
Hdfc Bank Limited
0
27 July 2012
Others
0
12 July 2012
Axis Trustee Services Limited
0
08 July 2009
Bank Of Bahrain & Kuwait Bsc
0
23 October 2006
D B S Bank Limited
0
23 September 2006
Centurion Bank Of Punjab Limited
0
21 July 2006
State Bank Of Indore
0
04 October 2010
Punjab National Bank
0
22 January 2009
Standard Chartered Bank
0
03 December 2009
State Bank Of Patiala
0
30 August 2007
Canara Bank
0
12 December 2005
State Bank Of Patiala
0
17 January 2009
Punjab National Bank
0
02 May 2012
Canara Bank
0
30 January 2012
Others
0
14 December 2011
Others
0
17 August 2011
Axis Trustee Services Limited
0
28 April 2010
State Bank Of Indore
0
30 October 2009
Indian Overseas Bank
0
10 October 2009
Others
0
21 July 2009
Development Credit Bank Limited
0
25 March 2009
Bank Of India
0
08 April 2008
Others
0
03 July 2007
Idbi Trusteeship Services Limited
0
04 July 2007
Centurion Bank Of Punjab
0
30 August 2006
Yes Bank Limited
0
29 March 2022
Others
0
04 December 2017
Others
0
05 January 2007
Others
0
20 July 2021
Others
0
27 May 2021
Others
0
02 January 2009
Others
0
11 February 2009
Others
0
25 February 2009
Others
0
20 July 2009
Others
0
04 September 2009
Others
0
22 September 2009
Others
0
20 January 2010
Others
0
09 March 2010
Others
0
12 March 2010
Others
0
17 March 2010
Others
0
28 September 2010
Others
0
27 December 2010
Others
0
31 March 2011
Others
0
07 April 2011
Others
0
25 April 2011
Others
0
24 September 2011
Others
0
19 August 2011
Others
0
28 February 2011
Others
0
21 October 2011
Others
0
20 December 2011
Others
0
28 March 2012
Others
0
27 September 2012
Others
0
14 January 2013
Others
0
05 February 2013
Others
0
21 March 2013
Others
0
24 April 2013
Others
0
20 June 2012
Others
0
16 July 2013
Others
0
27 September 2013
Others
0
20 December 1999
Others
0
31 December 2004
Others
0
04 May 2005
Others
0
10 March 2005
Others
0
10 March 2005
Others
0
22 June 2004
Hdfc Bank Limited
0
27 July 2012
Others
0
12 July 2012
Axis Trustee Services Limited
0
08 July 2009
Bank Of Bahrain & Kuwait Bsc
0
23 October 2006
D B S Bank Limited
0
23 September 2006
Centurion Bank Of Punjab Limited
0
21 July 2006
State Bank Of Indore
0
04 October 2010
Punjab National Bank
0
22 January 2009
Standard Chartered Bank
0
03 December 2009
State Bank Of Patiala
0
30 August 2007
Canara Bank
0
12 December 2005
State Bank Of Patiala
0
17 January 2009
Punjab National Bank
0
02 May 2012
Canara Bank
0
30 January 2012
Others
0
14 December 2011
Others
0
17 August 2011
Axis Trustee Services Limited
0
28 April 2010
State Bank Of Indore
0
30 October 2009
Indian Overseas Bank
0
10 October 2009
Others
0
21 July 2009
Development Credit Bank Limited
0
25 March 2009
Bank Of India
0
08 April 2008
Others
0
03 July 2007
Idbi Trusteeship Services Limited
0
04 July 2007
Centurion Bank Of Punjab
0
30 August 2006
Yes Bank Limited
0

Documents

Form MSME FORM I-03042021_signed
Form MSME FORM I-09012021_signed
Form MSME FORM I-09012021_signed
Form MSME FORM I-31122020_signed
Form DPT-3-25122020_signed
Form PAS-6-16092020_signed
Form DPT-3-31072020-signed
Approval letter for extension of AGM;-26022020
List of share holders, debenture holders;-26022020
Copy of MGT-8-26022020
Optional Attachment-(1)-26022020
Form MGT-7-26022020_signed
Approval letter of extension of financial year of AGM-30012020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30012020
XBRL document in respect Consolidated financial statement-30012020
Form AOC-4(XBRL)-30012020_signed
Form MGT-14-27012020-signed
Form MGT-15-08012020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-08012020
Optional Attachment-(1)-08012020
Form MGT-14-19112019_signed
Form MSME FORM I-16112019_signed
Form BEN - 2-29072019_signed
Declaration under section 90-29072019
Form DPT-3-27062019
Optional Attachment-(1)-14062019
Copy of MGT-8-14062019
List of share holders, debenture holders;-14062019
Optional Attachment-(2)-14062019
Form MGT-7-14062019_signed